APDH-Engineered Yeast Fermentation for High Arabitol Titers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods of xylitol production are costly and environmentally inefficient, and there is a need for a cost-effective and sustainable alternative that minimizes the production of metabolic intermediates like erythritol during fermentation.
Innovation Solution
Genetically engineered yeast cells, such as Moniliella pollinis, expressing an exogenous arabitol-phosphate dehydrogenase enzyme, are used to produce arabitol while reducing erythritol production, with the enzyme sequence having at least 60-100% identity to SEQ ID NO:11, and fermentation conditions optimized to enhance arabitol yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional chemically catalyzed hydrogenation is used for xylitol production, then production capacity is achieved, but environmental cost and operational complexity increase due to high temperatures, pressures, and metal catalysts required
Solution Approach 1:
The patent replaces the mechanical/chemical hydrogenation system with a biological fermentation system. Instead of using metal catalysts, high temperatures, and high pressures, the invention uses genetically engineered yeast cells that naturally produce xylitol through fermentation at ambient conditions, thereby eliminating the harmful environmental factors associated with traditional chemical processes
Solution Approach 2:
The invention changes the operational parameters from extreme conditions (high temperature, high pressure) to mild biological conditions (ambient temperature, atmospheric pressure). The fermentation process occurs at pH 4.5-6.0 and temperatures suitable for yeast growth, replacing the harsh chemical hydrogenation conditions
2Productivity
If traditional chemically catalyzed hydrogenation is used for xylitol production, then production capacity is achieved, but resource consumption increases due to large amounts of water and metal catalysts required
Solution Approach 1:
The patent replaces the chemical hydrogenation system requiring metal catalysts and large amounts of water with a biological fermentation system. The yeast cells use minimal water for metabolism and no external catalysts, as the catalytic activity is inherent to the biological system
Solution Approach 2:
The genetically engineered yeast cells self-catalyze the production of xylitol through their endogenous metabolic pathways. The cells automatically regulate the fermentation process, converting xylose to xylitol without requiring external catalysts or additional water inputs
3Productivity
If metabolic pathways for xylitol production are activated, then xylitol production increases, but production of alternative products like erythritol and arabitol occurs as unwanted side products
Solution Approach 1:
The patent extracts or removes the metabolic pathways responsible for producing unwanted side products like erythritol and arabitol from the yeast genome. By deleting specific genes encoding enzymes in these alternative pathways, the system directs all metabolic flux toward xylitol production, eliminating competing reactions
Solution Approach 2:
The invention modifies specific local regions of the metabolic network by deleting particular genes while leaving the rest of the metabolism intact. This localized genetic modification ensures high xylitol selectivity without disrupting overall cellular function
4Productivity
If genetically engineered yeast is used to produce arabitol, then arabitol titer increases, but production of alternative products like erythritol and ribitol may occur as metabolic intermediates
Solution Approach 1:
The patent removes competing metabolic pathways that produce erythritol and ribitol by deleting the genes encoding the responsible enzymes. This ensures that the metabolic flux is directed exclusively toward arabitol production through the introduced arabinitol-5-phosphate dehydrogenase enzyme
Solution Approach 2:
The invention performs preliminary genetic engineering to delete competing pathways before introducing the arabitol production pathway. This preparatory modification of the host organism ensures that when arabitol production is activated, there are no alternative pathways to divert metabolic intermediates
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered yeast cells achieve high arabitol titers of at least 20-100 g/L with reduced erythritol and glycerol production, offering a sustainable and cost-effective fermentation process.
Implementation Method 1
an exogenous polynucleotide sequence encoding an arabitol-phosphate dehydrogenase (APDH) enzyme
Implementation Method 2
fermentation processes have been used commercially at large scale to produce other organic molecules
Data Source
AI summary
Disclosed herein are genetically engineered yeast cells capable of producing arabitol. The engineered yeast cell may comprise an exogenous polynucleotide sequence encoding an arabitol phosphate dehydrogenase (APDH) enzyme comprising a sequence at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at CA least 99%, or 100% identical to SEQ ID NO: 11.